...
首页> 外文期刊>British Journal of Cancer >Amplification and expression of mdr1 gene in a multidrug resistant variant of small cell lung cancer cell line NCI-H69
【24h】

Amplification and expression of mdr1 gene in a multidrug resistant variant of small cell lung cancer cell line NCI-H69

机译:mdr1基因在小细胞肺癌NCI-H69细胞多药耐药变体中的扩增和表达

获取原文

摘要

Amplification and expression of the mdr1 gene encoding P-glycoprotein have been studied in H69/LX4 a multidrug resistant variant (MDR) of small cell lung cancer (SCLC) cell line NCI-H69. Recently a second independently derived MDR variant of this cell line designated H69/AR was found by others not to show amplification, rearrangement or over-expression of the mdr1 gene. The present study reports that in marked contrast to H69/AR, H69/LX4 shows amplification and expression of the P-glycoprotein gene and raises the possibility that P-glycoprotein hyperexpression may be a clinically relevant component of MDR in some SCLC tumours.
机译:已在小细胞肺癌(SCLC)细胞系NCI-H69的多药耐药变异体(MDR)H69 / LX4中研究了编码P-糖蛋白的mdr1基因的扩增和表达。最近,其他人发现该细胞系的第二个独立衍生的MDR变体H69 / AR没有显示出mdr1基因的扩增,重排或过表达。本研究报告指出,与H69 / AR明显不同的是,H69 / LX4显示P-糖蛋白基因的扩增和表达,并增加了P-糖蛋白过表达可能是某些SCLC肿瘤中MDR的临床相关成分的可能性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号